On March 27, Instituto Latinoamericano de Biotecnología MECHNIKOV received the GMP ( Good Manufacturing Practices in English) certification for the manufacturing process of the Fractionated Inactivated Influenza Vaccine indicated for the prevention of influenza. This is an important achievement for the Institute because it consolidates its leadership in the area of the production of Biological products in Central and Latin America.
This new GMP certification allows the MECHNIKOV Institute to expand its offer of services to third parties regarding the production and release of biological products .
This milestone has demonstrated the ability of the MECHNIKOV Institute to certify GMP of the production process, the first of its type, born of a project of technology transfer of the Institute of St. Petersburg vaccines. This has been possible thanks to the close collaboration and trust between the Pan American Health Organization (PAHO), the Ministry of Health of the Republic of Nicaragua, the Center for the Control State of Medicines, Equipment and Devices of the Republic of Cuba (CECMED).
MECHNIKOV Institute is a pioneer in the production of products Biologics in Central America, and is also involved in other technology transfer projects for treatment and prevention of other pathologies.
MECHNIKOV Institute has the know-how necessary to face manufacturing projects for third parties of biological products.
With this certification, the MECHNIKOV Institute is in a position to comply with international regulations to guarantee the quality, safety and efficacy of the Flu Vaccine.
